
Ethosuximide Coupons & Discount Card - Compare Prices Near You
generic Zarontin
My prescription
Edit
250MG, Ethosuximide (30 Capsules)
Select pharmacy

CVS
$21.72
COUPON PRICE
Rite Aid
$10.88
COUPON PRICE
Walmart
$12.40
COUPON PRICE
Albertsons
$18.09
COUPON PRICE
Walgreens
$19.72
COUPON PRICEEthosuximide savings card
Show this card to your pharmacist
CVS
$21.72
BIN
ID
PCN
GRP
019876
LH1C050490
CHIPPO
LHX
Powered by
Ethosuximide Side Effects
Interactions
What are the side effects of ethosuximide?
Ethosuximide may cause several side effects. Common side effects include nausea, vomiting, loss of appetite, weight loss, and dizziness. Some individuals may experience fatigue, headache, or hiccups. Less common but more serious side effects can include mood changes, depression, or suicidal thoughts. Rarely, it may cause blood disorders, liver problems, or severe skin reactions. It is important for individuals to report any unusual or severe symptoms to their healthcare provider promptly.
What class of drug is ethosuximide?
Ethosuximide is classified as an anticonvulsant medication. It is primarily used to treat absence seizures in patients with epilepsy.
What is the black box warning for ethosuximide?
Ethosuximide does not have a black box warning. However, it is important to note that ethosuximide can cause serious side effects, including blood dyscrasias, systemic lupus erythematosus, and severe skin reactions. Patients should be monitored for these potential adverse effects.
Does ethosuximide affect memory?
Ethosuximide is primarily used to treat absence seizures and is not commonly associated with significant memory impairment. However, like many antiepileptic drugs, it can have side effects that may include cognitive changes in some individuals. If there are concerns about memory or cognitive function while taking ethosuximide, it is advisable to consult a healthcare professional for a thorough evaluation and guidance.
Does fycompa have a black box warning?
Yes, Fycompa (perampanel) has a black box warning. It warns about the risk of serious psychiatric and behavioral reactions, including aggression, hostility, irritability, anger, and homicidal ideation and threats. Patients should be closely monitored for these reactions, and any significant changes in mood or behavior should be reported to a healthcare provider immediately.